2025金融赋能医疗健康产业（广西）创新会议在南宁成功举办

Group 1: Conference Overview - The "2025 Financial Empowerment of the Medical Health Industry (Guangxi) Innovation Conference" was successfully held in Nanning, focusing on building a closed-loop ecosystem of "technology innovation + capital empowerment + industry landing" to support the development of the medical health industry in Guangxi towards ASEAN [1][2] - The conference gathered experts from renowned medical schools, leading enterprises in the medical health industry, financial investment institutions, and ASEAN representatives to discuss the integration of technology and capital in the health sector [1][2] Group 2: Industry Insights - The Guangxi medical health industry is entering a critical phase of high-quality development, driven by continuous policy support and the need for an integrated ecosystem [1][2] - The medical health industry in China is currently experiencing a strategic opportunity period, with Guangxi positioned as a frontier for integration with ASEAN and artificial intelligence [2] Group 3: Company Strategies - Zhongheng Group has established a "1+6" industrial ecosystem centered on pharmaceutical manufacturing, focusing on deepening local medicinal resources, revitalizing traditional brands, innovating new drugs, and expanding into ASEAN markets [3] - The company aims to enhance the modernization of Guangxi's medical health industry and contribute to the "Healthy China" strategy through collaboration across the industry chain, innovation chain, and capital chain [3] Group 4: Investment and Financial Solutions - Guohai Securities provides a comprehensive financial solution for the medical health industry, integrating investment, investment banking, research, and wealth management [2][5] - Guohai Innovation Capital has transitioned from pure financial investment to a comprehensive investment platform, managing over 21.4 billion yuan and supporting multiple enterprises in entering the capital market [5] Group 5: Research and Development - The conference featured the release of the "2025 China Innovative Drug Industry Investment Blue Book," which analyzes the development trends and investment strategies in the innovative drug sector [4] - Discussions included the application of AI technology in pharmaceutical innovation and how digital transformation can drive industry upgrades [4] Group 6: Project Showcases - Ten quality enterprises showcased their projects during the conference, aiming to facilitate capital empowerment and precise matching with investment institutions [6] - Attendees also visited Zhongheng Group's industrial park to gain insights into the real dynamics of pharmaceutical manufacturing in Guangxi [6]